- Early parenteral prostacyclin therapy enables near-normal haemodynamics and treatment de-escalation in patients with haemodynamically severe pulmonary arterial hypertension. [Letter]Eur Respir J. 2026 Jul 16. [Online ahead of print]ER
- Publisher Full Text (DOI)
- Safety and efficacy of inhaled itraconazole in adults with asthma and allergic bronchopulmonary aspergillosis (PUR1900-ABPA): a randomized, double-blind, parallel group, placebo-controlled, multicenter, phase 2 trial. [Journal Article]Eur Respir J. 2026 Jul 16. [Online ahead of print]ER
- CONCLUSIONS: PUR1900 40 mg was associated with improvements across key clinical domains in ABPA, with a favorable safety profile, supporting further phase 3 evaluation.
- Publisher Full Text (DOI)
- It's more than mechanics: the case for metabolic endpoints in airways disease. [Editorial]Eur Respir J. 2026 Jul 16. [Online ahead of print]ER
- Publisher Full Text (DOI)
- ERJ Podcast June 2026: The ageing lung. [Journal Article]Eur Respir J. 2026 Jun; 67(6).ER
- Publisher Full Text (DOI)
- A new frontier for image markers in COPD. [Editorial]
- Publisher Full Text (DOI)
- Have we resolved anything yet about sarcoidosis trials? [Editorial]
- Publisher Full Text (DOI)
- FIBRONEER-ILD: taking a second look at the data. [Editorial]
- Publisher Full Text (DOI)
- Re-evaluating the role of reference equations in pulmonary function test interpretation. [Editorial]
- Publisher Full Text (DOI)
- Fostering trust in digital respiratory medicine: the open access ERS CONNECT digital health technology repository. [Letter]Eur Respir J. 2026 Jul; 68(1).ER
- Publisher Full Text (DOI)
- Thank you France for drastically raising tobacco taxes… It's time for others to follow! [Letter]Eur Respir J. 2026 Jul; 68(1).ER
- Publisher Full Text (DOI)
- Aberrant and Ectopic Cell Populations in Restrictive Allograft Syndrome after Lung Transplantation. [Journal Article]Eur Respir J. 2026 Jul 09. [Online ahead of print]ER
- CONCLUSIONS: Considering the multifaceted differences of RAS and idiopathic pulmonary fibrosis, we revealed a surprising general principle of an entity-spanning composition of the fibrotic niche by aberrant basaloid cells localized at the fibrotic edge, ectopic COL15A1[+] pVECs and CTHRC1[+] fibrotic fibroblasts. This suggests a flexible but cellular pathogenesis-guided transferability of potential therapeutic approaches between progressive fibrotic lung diseases.
- Publisher Full Text (DOI)
- Lung Transplantation for Pulmonary Alveolar Proteinosis - a Retrospective International Multi-Center Analysis. [Journal Article]Eur Respir J. 2026 Jul 09. [Online ahead of print]ER
- CONCLUSIONS: LTx provides excellent perioperative and long-term outcomes for patients with end-stage PAP and should be recommended in treatment guidelines. Although recurrence of PAP occurs in approximately 15% of cases, overall survival appeared unaffected in our limited dataset.
- Publisher Full Text (DOI)
- Beyond the 5th percentile: rethinking diagnostic thresholds in pulmonary function testing. [Journal Article]Eur Respir J. 2026 Jul 02. [Online ahead of print]ER
- Publisher Full Text (DOI)
- A Transcriptomic Atlas of Chronic Lung Allograft Dysfunction. [Journal Article]Eur Respir J. 2026 Jul 02. [Online ahead of print]ER
- CONCLUSIONS: CLAD is a spatially heterogeneous, yet molecularly continuous disease process, wherein BOS and RAS represent variable stages of a shared immunopathological continuum. Our findings support the development of lung-specific molecular classifiers to guide diagnostics and reveal novel targets for personalised therapies in transplantation.
- Publisher Full Text (DOI)